LinkedInXFacebook
Subscribe
Orthopedics This Week
  • Opinions
  • |My Feed
  • |Events
  • |Company Directory
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Press Releases/Spine/VB Spine Announces Successful First Clinical Cases of Vulcan™ Spinal System
Press ReleaseSpine

VB Spine Announces Successful First Clinical Cases of Vulcan™ Spinal System

By TJ HalvorsonMarch 11, 2026 2 min read Premium comments

Advertisement

VB Spine Announces Successful First Clinical Cases of Vulcan™ Spinal System
A dual lead screw from the Vulcan™ Spinal System / Courtesy of VB Spine LLC
Press Releasefirst clinical casesVB Spine LLCVulcan Spinal System

Milestone marks entry into Limited Market Release and builds momentum toward broader commercialization

NEW YORK, March 10, 2026 -(BUSINESS WIRE)- VB Spine LLC (“VB Spine”), today announced the successful completion of the first clinical cases utilizing the Vulcan™ Spinal System for thoracolumbar fixation. The milestone marks the system’s entry into Limited Market Release and represents a significant step forward in the company’s strategy to expand its next-generation implant portfolio.

The first case was performed on February 26 at MedStar Georgetown University Hospital in Washington, DC, marking the official clinical debut of the Vulcan Spinal System.

Continuing the system’s strong early clinical momentum, two additional surgeons at MedStar Georgetown University Hospital performed procedures following the first case. With three successful cases completed across two days, the early experience reflects an encouraging and energized start for the system.

The Vulcan Degenerative System was engineered to support fixation strength, surgical precision, and procedural efficiency while maintaining a streamlined workflow for the operating room. Designed in collaboration with surgeons, the system integrates advanced implant geometry and instrumentation intended to address the evolving demands of modern spine surgery.

“At VB Spine, everything starts with the patient,” said Marc Viscogliosi, co-CEO of VB Spine. “Moments like this represent patients placing their trust in innovation, in their surgeons, and in all of us behind the scenes. I’m proud of what the VB Spine team has been able to accomplish in this short period of time. We are grateful to the surgeons who partnered with us to develop this system and honored to support solutions designed to improve patient outcomes and advance spine care.”

The Limited Market Release phase will focus on gathering continued clinical feedback, supporting surgeon adoption, and ensuring operational readiness ahead of full commercial launch.

Regulatory and Availability

The Vulcan™ Spinal System is cleared by FDA for sale in the United States. It is intended for use in spinal fixation procedures to provide stabilization and support as part of a comprehensive surgical construct as an adjunct to fusion.

Forward-Looking Statements

Certain statements in this release are forward-looking and are based on current expectations, forecasts, and assumptions. Actual results may differ materially due to regulatory, commercial, and operational risks. VB Spine disclaims any obligation to update forward-looking statements except as required by law.

About VB Spine

Advertisement

VB Spine LLC is the largest privately held spine company and among the largest family-owned medical technology companies in the world. With a comprehensive portfolio and a large and growing global distribution network, VB Spine delivers specialized solutions that address critical needs in spine surgery and enhance patient outcomes. Focused on people, partnerships, and operational excellence, VB Spine ensures healthcare professionals have access to the tools and resources needed to provide the highest standard of care. VB Spine is owned and led by the Viscogliosi Brothers. For more information on VB Spine, please visit www.vbspineco.com.

Contacts

For media inquiries only:
spinecommunications@vbspineco.com

Author

TH
TJ Halvorson

The De Angelis Group | Orthopedics This Week | MSK Innovations

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

Orthopedics This Week’s mission is to connect the orthopedic community with the people, ideas, and innovations shaping the future of musculoskeletal care.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Opinions
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, opinions, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy